BackLENZ Therapeutics Overview

LENZ Therapeutics Receivables

LENZ Therapeutics's receivables is $340K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$343000.00

Peer average

Loading

LENZ Therapeutics Receivables History

Loading

LENZ Therapeutics vs. peers: Receivables Comparison

Loading

LENZ Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LENZ Therapeutics (LENZ) FAQ

LENZ Therapeutics (LENZ) currently reports a receivables of $340K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore LENZ Therapeutics's receivables history and peer comparisons.

LENZ Therapeutics's receivables changed from $0 to $340K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LENZ Therapeutics reported $340K in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $340K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LENZ Therapeutics, and consider following LENZ for alerts when major investors trade the stock.

LENZ Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $340K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LENZ with unrelated industries.